论文部分内容阅读
1 商品名 Lyrjca 2 开发与上市厂商本品由辉瑞公司研制开发,2004 年9月在英国首次上市,同年12月获美国许可。 3 适应证本品适用于成人外周神经性疼痛的治疗,以及成人有或无继发性全身性发作的部分性癫痫发作的辅助治疗。
1 Product Name Lyrjca 2 Developed and Listed Manufacturer This product was developed by Pfizer and listed for the first time in the UK in September 2004. It was approved by the United States in December of the same year. 3 indications This product is suitable for the treatment of adult peripheral neuropathic pain, as well as adults with or without secondary systemic seizures in partial seizures adjuvant therapy.